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ABSTRACT 
Background  
Congenital cytomegalovirus (cCMV) infection is the most common non-genetic cause 
of sensorineural hearing loss in childhood and an important cause of neuro-disability. 
There is no licensed CMV vaccine and no antenatal treatment for congenital CMV 
that is routinely recommended in clinical practice in the UK.  
 
Objectives  
To review the published literature for studies that evaluated preventative hygiene-
based interventions in pregnancy for their impact on knowledge about CMV 
prevention, the uptake of preventative behaviors or the acquisition of CMV in 
pregnancy.  
 
Search Strategy  
Searches were carried out in OVID Medline database and CINAHL. 
 
Selection Criteria 
All human studies, limited to women of childbearing age were included.   
 
Data Collection and Analysis 
Two reviewers independently assessed the quality of the methods and results of 
included articles. Extracted data were classified using Cochrane guidelines. 
 
Main Results 
Seven studies met the inclusion criteria. These show that preventative measures are 
acceptable to pregnant women, can impact their behavior, and have the potential to 
reduce CMV in pregnancy. They are limited by several factors; sample size, non-
randomized trial design and interventions that are beyond routine clinical practice.  
 
Conclusions 
An effective intervention that changes behavior in pregnancy and reduces the risk of 
CMV acquisition is needed as part of routine care. There is currently insufficient 
evidence about the form that this intervention should take.  
 
4  
 
Registration 
PROSPERO registration number: CRD42017069666 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5  
 
 
Introduction  
  
Cytomegalovirus (CMV) is the most common congenital infection in the UK. The 
estimated birth prevalence of congenital CMV (cCMV) is 0.3 - 0.7% 1,2 and it is more 
common than many better known congenital conditions, such as Down’s Syndrome, 
spina bifida or cystic fibrosis.3- 6  
 
The clinical presentation of CMV is wide-ranging. Around 10-15% of infants with 
congenital CMV will be symptomatic at birth and of these 40-60% will have life-long 
adverse sequelae, such as sensorineural hearing loss (SNHL), physical or cognitive 
impairment.2,3,7Of those babies who have no clinical features of congenital CMV at 
birth, around 10-15% will develop long term sequelae, particularly SNHL.2,7 CMV 
infection is the leading non-genetic cause of SNHL and the only potentially treatable 
condition.2,8,9,10  
 
Congenital CMV represents a significant public health issue, but there are currently 
no licensed CMV vaccines and no treatment for antenatal CMV infection routinely 
offered in the UK11 or worldwide.12 CMV is transmitted through contact with infected 
bodily fluids and pregnant women most commonly acquire infection through 
exposure to the saliva and urine of young children, especially their own children.13 
Reduction of pregnant women’s contact with infected urine or saliva from young 
children has therefore been identified as one of the most important potential 
preventative strategies to reduce antenatal CMV infection.14,15,16 Such advice is not 
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routinely provided as part of routine antenatal care in the majority of settings 
worldwide; however, advice is available online if women seek it, for example from 
the Centre for Disease Control and Prevention,17CMV Action,18 and the NHS.19  
 
Pregnant women are a group who are highly motivated to change behavior to protect 
the health of their developing fetus and are more receptive to healthcare messages 
than non-pregnant women.20 For example, a UK longitudinal study reported a notable 
reduction in smoking, alcohol consumption and intake of caffeinated drinks when 
women became pregnant, compared with the period before pregnancy.21 Furthermore, 
hygiene-based interventions can prevent other infectious diseases with similar 
transmission modes.22,23,24 
 
In the U.K., a recent qualitative study conducted on pregnant women suggested that 
that they felt let down by antenatal services as they were not told about CMV and 
therefore, did not have the opportunity to make decisions for themselves about 
whether to make changes to reduce their risk of CMV.25 
 
In this systematic review we sought to evaluate the published literature for studies that 
evaluated preventative hygiene-based interventions in pregnancy for their impact on 
knowledge about CMV prevention, the uptake of preventative behaviors or the 
acquisition of CMV in pregnancy.  
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Methods 
 
Study design 
The protocol for this study was designed using the Preferred Reporting Items For 
Systematic Review and Meta-Analysis Protocols and included the objective of the 
search, the search strategy, eligibility criteria and planned methods of quality 
assessment. PROSPERO registration number: CRD42017069666.  
Selection of studies  
The literature search was conducted using Medline and CINAHL databases and the 
Clinical Trials Registry of the National Institutes of Health was also searched to 
identify ongoing studies. No time limit was set. The reference lists of relevant articles 
were also searched, and additional studies were included if they fulfilled the inclusion 
criteria. The following search terms were used in different combinations: congenital 
cytomegalovirus, antenatal, prenatal, prevention, hygiene, intervention, pregnancy, 
hand wash, infection control. The full search strategy can be found in supplementary 
information. The literature search was completed in February 2019.  
 
We included all randomized controlled trials (RCTs), non-randomized controlled 
trials, observational studies and case series. Studies were required to have included 
some women who were pregnant, of child bearing age or attempting pregnancy; 
studies were only included if they were reported in English; studies that tested 
interventions to prevent CMV infection via other routes of transmission or in other 
groups of patients (i.e. HIV, transplant, blood transfusions) were excluded. There 
were no publication date restrictions. Outcome measures included: effectiveness of 
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hygiene-based interventions (e.g. on cCMV or on seroconversion rate), adherence to 
protective behaviors, barriers to behavior change, adverse effects of intervention and 
change in knowledge about CMV.   
 
Title and abstract screening using the above inclusion and exclusion criteria, was 
performed by three blinded reviewers (VB, AC, CJ) using Rayyan QCRI. The full text 
versions were reviewed in a blinded manner by the same authors. Any disagreements 
were resolved through arbitration from the other authors (TV). In addition, manual 
searching of full texts’ reference list was undertaken.  
 
Data extraction and management  
Data was extracted independently by two authors (AC and VB) using a standardized 
extraction form.26 Data extracted included: location, study design, sample, 
intervention, randomization procedure, blinding, nature of control group, method of 
outcome assessment and results.  
 
Risk of bias assessment  
Two authors (VB and AC) independently reviewed the studies that met the inclusion 
criteria and assigned a quality rating determined by the number of valid criteria met.  
An overall validity assessment rating for each trial was applied using the Cochrane 
Risk of Bias tool.25 If there was any disagreement after unblinding, a third author 
arbitrated (TV).   
 
Methodologic strength of RCT’s was evaluated using the following criteria: allocation 
concealment, blinding of outcome assessors and completeness of follow up data and 
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for non-experimental studies: control of confounding variables, blinding of outcome 
assessors and completeness of follow-up data. If one or more validity criteria were not 
met, the study was considered to have a high risk of bias.  
 
Data synthesis 
Individual study characteristics were summarized in a descriptive table.   
 
Results 
 
The search yielded 763 articles, 447 of which were selected for abstract evaluation, 13 
for full text evaluation and 7 for inclusion in the systematic review. Reason for 
exclusion can be found in Figure 1. Characteristics and scores of methodologic 
quality of the seven studies can be found in Table 1.  
 [Figure 1 here] 
 
[Table 1 here] 
The significant heterogeneity among the included studies prevented us from 
conducting a meta-analysis in order to pool their results. 
 
Three studies were randomized controlled trials,20,27,28 two were pre-test post-test 
design,29,30one was a case series31 and one was an observational study.32 The studies 
were conducted in the USA,20, 27-30 France31 and Italy.32 
 
The study populations were varied. Three exclusively recruited pregnant 
women,28,31,32 two recruited women with a young child who were either pregnant or 
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planning a pregnancy,20,30one recruited women with a young child in day care 
irrespective of their pregnancy status27 and one recruited exclusively non-pregnant 
women with a young child in day care.29   
 
Intervention 
In Adler et al. (1996)27 50 mothers were randomized to one of three groups. Mothers 
in the education intervention (E) were given written and oral instructions for 
protective behaviors (frequent hand washing, wearing gloves for diaper changing and 
avoiding intimate contact with their child) and bi-weekly home visits were conducted 
to assess adherence (n=11). A second education intervention group (A) included an 
additional demonstration and practice of hand washing and glove changing 
techniques, as well as bi-weekly home visits with a research nurse to problem solve 
and provide positive reinforcement (n=8). The control group (C) received basic 
information about CMV but no intervention (n=17) and the fourth group of pregnant 
women (P) received an intervention equivalent to the education group (E), with the 
exception of home visits (n=14).  
 
Building on the initial study, the same authors conducted a second study20, where 
mothers (n=115) in the intervention group received the identical intervention as 
mothers in the initial study27 who were randomized to the adherence and education 
group (A) with the addition of an educational video demonstrating protective 
techniques for avoiding acquisition of CMV (length of video unknown). The control 
group (C) received basic information about CMV but no intervention (n=51). The 
other difference in this trial was that mothers in the intervention group were informed 
of their serological status but were unaware if their child was shedding CMV.  
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In the only case series study,31 pregnant women (n=5312) were provided with hygiene 
counselling on CMV prevention. Detailed oral and written hygiene information was 
given to seronegative mothers (and partners) by an obstetrician or midwife at the first 
general visit (12 WG). The information given was similar to 1996 Adler et al.27 study, 
except wearing protective gloves was not recommended.  
 
The intervention in the Revello et al.32 study included pregnant women (n= 646) 
undergoing genetic screening in a hospital who have frequent contact with young 
children (own child or working with children < 36 months) and who were either 
CMV-seronegative or had not tested for CMV immune status. Seronegative women in 
the intervention group (n=331) received a 15-minute written information session 
explaining potential techniques for avoiding CMV acquisition and were given 
pictorial cards showing protective and risky behaviors to take home. In addition, a 5-
minute session at follow-up visits (18 WG) and a questionnaire every 6 weeks from 
18 weeks of gestation was scheduled to reinforce hygiene messages. 
 
In Hughes et al.28 pregnant women (n=223) who were screened for CMV serology 
during prenatal care before 20 WG were randomized into either the intervention group   
(n= 124) or the standard care group (n= 63) based on their serostatus (positive or 
negative). The intervention consisted of a 5-minute in office video with hygiene 
teaching, a take home calendar and weekly text message reminders. The control group 
received standard care in the form of a brochure about CMV acquisition. Those with 
primary CMV infection were excluded. 
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In the earliest reported study,29 the intervention was administered to non-pregnant 
mothers (n=11) of young children (< 18 months of age). The intervention consisted of 
a 15-minute education session for each mother with a physician and written 
instructions about protective and risky behaviors similar to the previous studies. In 
addition, mothers were provided with gloves and soap at weekly home visits. 
Adherence was measured by self-reported percentages (0–100%) of protective or 
risky behaviors conducted each week for 6 weeks. The number of gloves, and soap 
remaining at each weekly home visit also measured adherence to protective behaviors. 
 
Lastly, in the study by Price at al.30 women who were pregnant (n=328) or planning a 
pregnancy and who had a child under the age of 5 (n=481) were randomly assigned to 
one of two intervention groups to test the effect of two educational based 
interventions to determine whether they increase knowledge about CMV, motivate 
information seeking behavior and lead to adoption of CMV prevention behaviors.  In 
the first intervention women (n=404) were shown a one-page fact sheet about CMV 
acquisition and prevention strategies. In the second intervention women (n=405) were 
shown a 5-minute video, which included a first-person story of mothers’ experiences 
with CMV, and information on acquisition of CMV and preventative strategies by a 
physician.  
 
Change in knowledge 
Only one paper explicitly investigated change in knowledge following an educational 
intervention.30 Twelve questions assessed CMV knowledge before and immediately 
after presentation of CMV health education material. Questions were in ‘true’ or 
‘false’ format and related to transmission of CMV. In this study the knowledge score 
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increased significantly after presentation of the film or factsheet (P = < 0.001) with a 
suggestion that the video may have been more effective than the factsheet. 
  
Change in behavior  
Six of the papers assessed participants’ attitudes and behaviors to CMV prevention, 
although the methods varied.20, 27-30,32Three studies exclusively used self-reporting for 
assessment of the change in attitudes to preventative behaviors following the 
educational intervention.27,30,32 Price et al.30 used a survey delivered before and after 
one of the two interventions where participants recorded their level of agreement with 
a series of statements about engagement with preventative behaviors. They found that 
participants were strongly in agreement with the statements after receiving both of the 
educational materials (film or written information).  In Revello et al.32 participants 
were asked about actual behaviors by completing a questionnaire every 6 weeks from 
18 weeks and found that the respondents followed the recommendations often (66%) 
or always (14%). Hughes et al.28 also asked about current compliance with hygiene 
precautions at baseline and after the intervention or comparison. They found that 
reported behavioral compliance increased more in the intervention group than the 
control group (P = 0.007), although the qualitative data suggested that both the 
intervention group (behavioral intervention in clinic) and the control group (written 
information only) changed their behaviors.  
 
Three papers included an objective assessment alongside self-reported measures of 
behavior change.20,27, 29 In all three, women were asked about the percentage of 
opportunities where they performed protective or risky behaviors and measured soap 
and glove use. In Finney et al.29 they reported an increase in protective behaviors and 
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a decrease in risky behaviors following education which was supported by the 
objective assessment. Adler et al’s.27 first study reported more self-reported hand 
washing in the group who received the enhanced intervention compared with the 
standard educational intervention but with no difference in the objective assessment 
of soap use, and in the later study,20 no association between self-reported behavior 
change and objective assessment of adherence was reported.  
 
Reduction of acquisition of CMV 
Four studies assessed the impact of an intervention on rates of seroconversion,20, 
27,31,32 with two reporting that educational interventions significantly reduced 
seroconversion in participants.31,32 Firstly, Revello et al.32 showed a significantly 
lower seroconversion rate in the intervention (4/331) compared with the comparison 
(24/315) group (P = <0.001), which remained significant after adjustment for 
potential cofounders. This reduction rate equates to a number needed to treat of 16 
(95% CI: 10-30).  The second study31showed reduced seroconversion in the period 
following the educational intervention provided at around 12 WG (5/2583), compared 
with the first 12 weeks of pregnancy (11/2594), giving a significantly lower infection 
rate per woman in the period between 12 and 36 WG (0.008%) than in the period 
before 12 weeks (0.035%).  Among the 16 women who seroconverted, 15 were at high 
risk of infection, 12 women had a child younger than the age of 3 at home, and 7 were 
paediatric nurses or doctors. This supports the need for hygiene information to be 
focused on the handling of young children. The lower incidence of CMV infection 
after 12 WG is also an important result as the risk for more serious damage to the 
fetus occurs with early trimester infection.33 Therefore, the timing of any intervention 
must be considered.  
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In Adler et al’s27 first study they reported non-significantly reduced rates of 
seroconversion between intervention (E: 4/11, A: 2/8, P: 0/14) and control groups 
(8/17, P < 0.29). This study also showed that the rate of infection was statistically 
lower in pregnant women compared to non-pregnant women irrespective of the 
randomized group. In Adler et al.’s20 subsequent study they reported no difference in 
the seroconversion rate between the intervention and control groups (9/115 in both 
groups) but reported significantly reduced seroconversion in those pregnant (1/17) at 
the time of enrolment compared with women attempting conception (10/24, P = 
0.008). These results suggest that an intervention for pregnant women is effective 
because these women will perceive a higher risk and be more motivated to adhere to 
recommendations than non-pregnant women. 
 
Acceptability 
Three papers assessed acceptability of educational interventions for CMV risk 
reduction in pregnancy.  Overall, it was found that interventions were not associated 
with adverse effects such as alarm, early termination of pregnancy31 or an increase in 
psychological distress28 and that recommendations were perceived to be worth 
providing to all pregnant women at risk of infection.32 
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Discussion 
Main Findings 
The findings from this review provide preliminary support for the implementation of 
hygiene-based interventions in pregnancy, but the studies are heterogeneous in their 
study populations, the interventions being offered and the outcomes being studied, 
which makes it hard to draw firm conclusions about the comparative value of the 
interventions being offered.   
 
The one study which commented on change in knowledge reported an increase 
following the educational intervention30 and all of the studies which reported on 
changes in preventative behaviors or attitudes towards them showed that the 
educational intervention did change attitudes, behaviors or predicted behaviors in 
women if they were pregnant, but the differences in the studies make it hard to fully 
understand the impact of separate educational interventions. Two of the four papers 
which investigated rates of seroconversion showed that hygiene-based interventions 
reduced the risk of seroconversion and both of these studies included only pregnant 
women.31,32 The two papers which showed no statistically significant difference in 
rates of seroconversion included both pregnant and non-pregnant women and both of 
these commented that the rate of seroconversion was lower in pregnant women 
(although not significantly).20,27 This may be because of behavioral differences in 
pregnancy or, as the authors suggest, that women in pregnancy are more motivated to 
engage with educational interventions and to make lifestyle changes. 
 
Few papers investigated differences between different educational interventions but 
one study30 suggested that the video may have been slightly more effective than the 
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factsheet, but that the difference was too small to be able to draw definitive 
conclusions. The broader health literature provides some support that interventions in 
video formats can be more effective than written,34 particularly among low literacy 
populations.35  
 
Strengths and Limitations 
The studies in this review were of small sample size,20,27 under-powered27 or         
non-randomized 31,32 and the majority where carried out in the USA20,27-29,31 and two 
countries within Europe,31,32 limiting the extrapolation of results to healthcare settings 
in other countries. The diversity of the included populations, particularly the inclusion 
of both pregnant and non-pregnant participants, and the variation in healthcare 
settings and interventions make it hard to compare the impact of different 
interventions.  
 
In the studies that assessed behavior change, 28, 30,32 self-report and indirect objective 
measures were used which may be unrelated to actual behavior change and so 
provides evidence about intended behavior change rather than actual behavior change. 
Therefore, this should be seen more as a marker of changes in attitude rather than 
behavior. Furthermore, one of the studies asked participants to reflect on whether their 
behavior would be different if they were pregnant, which is likely to yield different 
results than asking people about their current behavior.   
 
In the Price et al study,30 the post intervention assessments were conducted 
immediately after the intervention and it is therefore possible that if re-tested at a later 
time point, the impact might have been diminished. Importantly, there were no direct 
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behavioral measures (only self-reported data) in this study therefore it is not clear 
whether the women would actually adhere to these prevention behaviors.  
 
The intensity of all of the interventions in this review and the consequent demands on 
staff are likely to be unrealistic in routine healthcare, all lasting between 10-20 
minutes and requiring a medical professional. The interventions mostly took place 
during routine antenatal care visits and at one time point, which again is not feasible 
in routine healthcare as there is already so much to discuss in these visits. The current 
literature on alcohol prevention among pregnant women seems to point to the 
effectiveness of an intervention administered by a physician and integrated into 
obstetric care in primary care setting.36-38Although, interventions administered in a 
community setting and by non-professionals have also been found to reduce alcohol 
use among pregnant women.39 
 
Three of the studies included instructions for glove use when diaper changing (in 
addition to washing hands) as a protective behavior,20,27,29 which is unrealistic,  
impractical and is not included in the recommendations that can be found online.17-19  
 
The replication of reinforcement methods that some of the studies use in this review 
such as home visits,20,27 text message reminders28 and frequent questionnaires 32 are 
also unrealistic in a routine clinical care setting. Therefore, it is clear that an 
intervention is needed which works not only in a clinical trial, but is feasible for 
routine healthcare.    
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Interpretation 
The results suggest that, particularly in pregnancy, educational interventions may 
increase knowledge about CMV and how to prevent it, increase compliance with 
preventative behaviors and reduce seroconversion, but the heterogeneous nature of the 
current studies make it hard to generate firm conclusions.  
 
In addition, the results also suggest that pregnant women are highly motivated to 
change their behavior in order to protect their fetus. This supports a wider literature 
that suggests pregnant women (and those attempting conception) are highly motivated 
to adopt positive lifestyle changes,21,36-38 making this group of women more receptive 
to healthcare messages.  
 
Conclusion  
An effective intervention is needed that can reduce the risk of CMV acquisition in 
pregnancy and can be offered as part of routine healthcare. There is insufficient 
evidence at present about the form that this intervention should take as the studies to 
date are based on intensive counselling requiring more time from healthcare 
professionals than would typically be available within routine maternity care. Large 
scale RCTs are needed to assess the effectiveness of an educational intervention on 
antenatal acquisition of primary CMV infection and determine the feasibility of this 
approach in a routine healthcare context.  
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 Table 1. Study characteristics and methodological quality of included studies   
Citation  Design; country; 
sample size 
Participants  Intervention Outcome Risk of bias  
Adler et al. 
199627 Cluster RCT; USA; n=50  Seronegative women (n=116) with a child 
<36 months, shedding  
CMV and enrolled in 1 of 15 
day-care centres in Richmond, 
Virginia, USA.  
39 participants 
unavailable, 12 refused 
to participate and 12 
excluded from the 
Education intervention (E, 
n=11): Written and oral 
info + bi-weekly home 
visits to measure 
adherence 
Education and adherence  
intervention (A, n=8): as 
above +    bi-weekly visit 
to problem solve and 
reinforce adherence  
Seroconversion: 
Controls: 47% 
E: 36.4%  
A: 25%   
P: 0% 
P < 0.29 
RS: low AC: low BP: n/a BO: n/a IO: low SR: low  CF: high  
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analysis because child 
stopped shedding 
CMV after enrolment.  
Pregnant (P, n=14): 
written and oral info 
Control (C, n=17): basic 
info only 
Adler et al. 
200420 Cluster RCT; USA; n= 166  Mothers (n=234) who were either pregnant or attempting 
pregnancy and had a child < 36 
months enrolled in 1 of 124 
childcare centres, Central, 
Northern, Eastern Virginia, 
USA. 42 excluded as CMV-
seropositive at enrolment, 26 
failed to provide follow-up 
specimens.   
Intervention 1 (n= 92, 
child’s shedding 
unknown): written, oral 
and video info + adherence 
visits 
Intervention 2 (n=23, 
child’s shedding known): 
written, oral and video + 
adherence visits 
Control group (C, n=51): 
Seroconversion:  
Control: 7.8% 
Intervention : 7.8% 
P= 1  
Pregnant: 5.9% 
Attempting 
pregnancy: 41.7% 
P= .008   
RS: low AC: low BP: n/a BO: n/a IO: low SR: low CF: not assessable 
 28  
 basic info only 
Citation  Design/country/s
ample size 
Participants  Intervention  Outcome  Risk of bias  
Valoup-
Fellous et al. 
200931 
Case series; 
France; n = 5173 
Pregnant women (n= 5312) 
who had their first medical 
visit to an obstetric department 
between January 2005 and 
December 2007 and had been 
followed until end of 
pregnancy, 139 refused CMV 
screening.  
Detailed oral and written 
hygiene information 
administered by 
obstetrician or midwife 
Seroconversion: 
0 - 12 WG: 0.42%,   
12 - 36 WG: 0.19%,  
P < 0.005 
CV: not assessable BO: n/a CF: low  
Revello et al. 
201532 
 
Interventional and 
observational 
controlled; Italy; 
Pregnant women (n= 4096) 
undergoing genetic screening 
in an Italian hospital who have 
Intervention (n=331): 
written and oral info + 
reinforcement + adherence 
Seroconversion:  
Intervention: 1.2%  
Comparison: 7.6% 
CV: low BO: n/a CF: low 
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n = 646  frequent contact with young 
children (own child or working 
with children < 36 months) and 
who were either CMV-
seronegative or had not tested 
for CMV immune status. 
questionnaire 
Comparison group 
(n=315): women not 
tested or informed about 
CMV during pregnancy 
(serum sample stored) 
delta=6.4%; 95% CI 
3.2 - 9.6; P < 0.001 
  
  
Table 1. (continued)  
Citation  Design/country/sample 
size 
Participants  Intervention  Outcome  Risk of 
bias  
Hughes et al. 
201728 
RCT: USA; n = 187  Pregnant women 
(n=223) who were 
screened for CMV 
Intervention (n=124): 5 
minute video with hygiene 
teaching + take home 
Behavioural 
compliance: 
Intervention: mean: 
RS: low AC: low BP: n/a 
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serology during 
prenatal care before 20 
WG, 26 did not meet 
inclusion criteria, 1 
miscarried, 4 withdrew, 
1 crossed over to 
control, 1 crossed over 
to intervention.  
calendar + weekly text 
message reminders 
Control group (n=63): 
standard care  
7-point increase 
from 80.7 to 87.7, 
95% CI 2.4-5.9 
Control: 4-point 
increase from 79.7 
to 84.1, 95% CI 
5.9-8.4 
Mean difference:  
3.0, 95% CI , 0.8-
5.2; P = 0.007 
BO: n/a IO: low SR: low  CF: low  
Finney et al. 
199329 
Pre-test Post-test; USA;  
n = 11  
Mothers (n=11) who 
had a child  <18 months 
enrolled in one of three 
day-care centres, 
15 minute education session 
with a physician and written 
instructions 
 
Hand washing and 
glove use 
increased.  
“Risky” behaviours 
CV: high BO: not assessable  CF: not 
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Virginia, USA.  decreased: 14.4% - 
5.1% 
assessable 
Price et al. 
201430 
Pre-test Post-test; USA;      
n = 809  
African-American 
(n=404) and Caucasian 
women (n=405), who 
had a child < 5 years 
and were either 
pregnant (n=328) or 
planning a pregnancy 
(n=481). 
Intervention 1 (n=404): 
written info  
Intervention 2 (n=405): 5 
minute video  
Knowledge score: 
Intervention 1 and 
2:  37% - 91%,               
P < 0.001  
CV: high BO: not assessable CF: not assessable 
 
RCT, randomised controlled trial; RS, random sequence generation (selection bias); AC, allocation concealment (selection bias); BP, blinding of 
participants (performance bias); BO, blinding of outcome assessment (detection bias); IO, incomplete outcome data (attrition bias); SR, selective 
outcome reporting (reporting bias); CV: control of confounding variables; CF: completeness of follow up data; n/a: not applicable; WG, weeks’ 
gestation. 
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Figure1. PRISMA Flow Diagram 
 
 
